Über uns

À propos de nous

Nachhaltigkeit

Durabilité

Open Access

Karriere

Carrière

Datenschutz

Protection des données

Impressum

Mentions légales

Zahlung und Lieferung

Paiement et livraison

LEXIA

LEXIA Arbeitsrecht

Was ist LEXIA?

C'est quoi LEXIA ?

LEXIA Familienrecht

Zeitschriften

Revues

recht

Pflegerecht

ZBJV

forumpoenale

ZStrR

Anwaltsrevue

Revue de l'avocat

RSAS

FamPra.ch

ASYL

Life Science Recht

BlAR

Sachbuch

Livres spécialisés

LOKI

Semaphor

Fokusthemen

Focus

Thema

Recht studieren

Arbeitsrecht

Droit du travail

Studium

Études

Familienrecht

Droit de la famille

Sozialversicherungsrecht

Droit des assurances sociales

Strafrecht

Droit pénal

Publikationen

Publications

Literatur

Onlinemodule LEXIA

Modules en ligne LEXIA

Bücher

Livres

Buchreihen

Collections

Datenbanken

recht.ch

Studienliteratur

Littérature pour les études

Services

Dienstleistungen für

Corporate Books

Publishing Lösungen

Aktuelles

Geschäftskunden

Professionnels

Corporate Publishing

Content solutions

Buchhandlungen

Librairies

Veranstaltungen

Événements

Presse

Dozierende

Enseignants

Studierende

Étudiants

Inserierende

Annonceurs

Newsletter

Blog

Autorinnen/Autoren

Auteurs

Unsere Schreibenden

Hilfe

Unsere Autorinnen und Autoren

Liste

Autorenlounge

Espace des auteurs

Bei uns publizieren

Publier chez nous

Autorenstimmen

Témoignages

Verlag

Éditions

Themen

Mehr wissen

Mitarbeitende

Collaborateurs

Geschichte

Histoire

Vision und Mission

Vision et mission

Unser Magazin

Notre magazine

Unternehmenskultur

Culture d'entreprise

Partner

Partenaires

Kontakt

Contact

Shop

Schweizer Recht

Ausländisches Recht

Über unseren Shop

Neuerscheinungen

Nouveautés

Unsere Funktionen

Nos fonctions

Vorankündigungen

À paraître

Nach Rechtsgebiet

Par domaine juridique

Kommentare

Commentaires

Gesamtkatalog

Catalogue complet

An urgent call to build a new model for the pharmaceutical industry, from the multi-award-winning Times journalist

Kenber B: Sick Money

Sick Money

The Truth About the Global Pharmaceutical Industry

Focusing on social types during the July Monarchy, Pauline de Tholozany argues that the popularity of typologies in France participated in the construction of a national ideal conceived as a sum of individual parts. Tholozany shows that types such as the dandy, flâneur, and grisette abounded in plot-riven literary genres and in journalistic sketches, signaling a fear of obsoleteness that continually evolving printing technologies cast on social thought, thereby inaugurating a new way of thinking about society.

The (Un)Making of National Identity in France

Social Types in Nineteenth-Century French Literature and Journalism

Fear and Loathing in the Philippines

President Rodrigo Duterte and the War on Drugs

Routledge Studies in Crime, Security and Justice

This book offers a novel perspective for conceptualising legality in market exchanges. It challenges the conventional binary of "legal" versus "illegal" markets by introducing the concept of variably legal markets - arenas of exchange where legality is conditional, multidimensional, and context-dependent.

Rethinking Markets and Crime

Variably Legal Markets

An acclaimed economist’s fully revised and expanded guide to how resilient thinking helps us thrive in a world filled with unknown risks &nbsp; Risks are ubiquitous in our world. In recent years, a changing global order, the war in Ukraine, food insecurity in emerging and developing economies, the COVID pandemic, and increasingly severe weather events have exposed our vulnerabilities and heightened our awareness that large, unexpected events can upend our lives at any moment. Describing how individuals, institutions, and nations can successfully navigate a dynamic, globalized economy filled with unknown risk, Markus K. Brunnermeier argues for adopting resilience as a central tenet of decision-making. Different from risk avoidance—which involves a cost-benefit analysis by weighing the outcome of various scenarios and choosing the less risky one—resilience focuses on the ability to bounce back from shocks and setbacks. &nbsp; Written for business leaders, economists, policymakers, and politically interested individuals, this wholly revised edition of the award-winning The Resilient Society applies macroeconomic insights to public health, innovation, public debt overhang, inflation, inequality, climate change, and other challenges to the global order. Brunnermeier shows how the concept of resilience can be a compass for developing a social contract that benefits us all.

The Resilient Society

Swedish Studies in European Law

How should EU law respond to emergencies? More specifically, to what degree can fundamental rights be suspended in order to respond to an unprecedented crises? These questions are at the core of this open access book, asked initially in response to COVID-19 and its resulting restrictions but then as a more general conceptual examination. It looks at the question over five parts; opening with two general aspects: constitutional law and governance. It then takes a more applied approach, looking at three case studies: migration, climate change, and, of course, the COVID-19 pandemic. Fascinating, insightful and considered, it ensures lessons can be learnt. The ebook editions of this book are available open access under a CC BY-NC-ND 4.0 licence on bloomsburycollections.com. Open access was funded by the Swedish Studies Network.

The Case of Covid-19, Climate Change and Migration

Emergency and EU Law

A sharp history of journalism's digital unraveling in the age of algorithms. In the past three decades, the battle between big tech and big journalism has reshaped how we consume the news. Jason Whittaker delves into how tech giants outmaneuvered traditional media companies, siphoning off advertising revenue and audience attention. As journalism struggled to adapt, social media platforms evolved from utopian public spaces into breeding grounds for misinformation and fake news, eroding public trust. The influence of billionaires further complicated the digital ecosystem, swaying public opinion and exercising direct political power, of which previous media moguls could only dream. More recently, AI has begun to revolutionize content creation, distribution, and consumption. Overall, this thirty-year period has witnessed a tangled mix of progress, contention, and disinformation. Incorporating stories about The Washington Post, The New York Times, The Atlantic, The Los Angeles Times, Bloomberg, and many other media outlets from around the world, and discussing key figures and companies in big tech and AI like Facebook/Meta, Cambridge Analytica, Google, Microsoft, Twitter/X and Elon Musk, Edward Snowden, Jakob Uszkoreit, OpenAI, ChatGPT, DeepSeek, and more, Whittaker provides an incisive examination of the frequently combative relations of these two industries and the uncertain future of the news in the digital age.

Big Tech v. Big Journalism

You Want What We've Got

Leadership in Global Health outlines the essential leadership principles that transform promising health interventions into global movements, offering a timely and compelling blueprint for leaders seeking to drive lasting, scalable change.Grounded in decades of lessons from global health successes and failures, and illustrated through deeply analyzed, real-world case studies, the book reveals what happens when leadership meets coordinated action. These stories - from the eradication of smallpox and the large-scale delivery of malaria bed nets to the community-based innovations of Ethiopia's Health Extension Program and the lightning-fast COVID-19 vaccine rollout - show how leadership in global health is not one-size-fits-all, but rather dynamic, responsive, and deeply human. In an era where complex health challenges range from emerging pandemics to enduring inequities, the book centers the role of leadership-strategic, adaptive, and collaborative-as the critical engine for scaling health interventions, offering readers not only compelling narratives from the field, but also practical tools and reflections which give the book a forward-looking focus.Building to offer a roadmap for developing the next generation of global health leaders equipped to thrive in multi-sectoral, rapidly evolving environments, it will be essential reading for students, scholars and practitioners across Global Health, Public Health, Leadership and Development Studies.

A Strategic Blueprint for Scalable Change

Leadership in Global Health

Code of Federal Regulations, Title 42 Public Health

Title 42 presents regulations that apply to: medical personnel; medical care and examinations; health related grants; fellowships, internships, and training; quarantine, inspection, and licensing; occupational safety and health research; health assessments; vaccines; Medicare and medical assistance programs; and standards and certification of facilities and services. Additions and revisions to this section of the code are posted annually by October. Publication follows within six months.

Code of Federal Regulations, Title 42 Public Health 414-429, 2025

Drugs and the Pharmaceutical Sciences

Pharmaceutical Process Engineering

Previously known as Drafting Agreements in the Biotechnology and Pharmaceutical Industries, this title provides precedent agreements for the main types of commercial transaction encountered in the life sciences, biotechnology and pharmaceutical industries. In addition to the print version, each precedent is available via an accompanying website in a format which can be easily downloaded and edited. Detailed commentary on legal, commercial and practice issues accompanies every precedent. Provided by specialist lawyers from across Europe, this commentary also highlights important differences between English law and that of other key EU jurisdictions: Germany, France, the Netherlands, Spain and Sweden. Commentary on specific considerations for the US is also provided. In addition to precedent commentaries, the book also contains detailed commentary and discussion of legal issues common to the life sciences, biotechnology and pharmaceutical industries, as well as links to relevant materials (eg regulatory materials on clinical trials). This title is included in Bloomsbury Professional's Intellectual Property and IT online service.

Drafting Agreements in Life Sciences

Outlines the urgent response needed to address privatization, which has led to dramatic but largely overlooked consequences for human rights.

Destroying the Social Contract and Empowering Corporate Actors

Privatizing Human Rights

Sick Money

Autres titres sur ce thème